Guangjun Nie Selected Research

Antigens

11/2023	Outer Membrane Vesicle-Based Nanohybrids Target Tumor-Associated Macrophages to Enhance Trained Immunity-Related Vaccine-Generated Antitumor Activity.
10/2023	Biogenetic Vesicle-Based Cancer Vaccines with Tunable Surface Potential and Immune Potency.
1/2023	Site-Specific Modification of Virus-Like Particles for Exogenous Tumor Antigen Display and Minimizing Preexisting Immunity.
11/2022	Direct Presentation of Tumor-Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell-Mimicking Nanovaccines.
1/2022	Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria.
1/2022	Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post-Photothermal Therapy.
10/2021	In Situ Transforming RNA Nanovaccines from Polyethylenimine Functionalized Graphene Oxide Hydrogel for Durable Cancer Immunotherapy.
1/2021	Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology.
1/2021	A DNA nanodevice-based vaccine for cancer immunotherapy.
1/2021	Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guangjun Nie Research Topics

Disease

143	Neoplasms (Cancer) 04/2024 - 01/2002
19	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2014
17	Breast Neoplasms (Breast Cancer) 10/2023 - 02/2014
15	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 04/2015
8	Melanoma (Melanoma, Malignant) 10/2023 - 09/2012
7	Inflammation (Inflammations) 05/2024 - 07/2013
5	Fibrosis (Cirrhosis) 04/2023 - 10/2013
5	Iron Overload 03/2022 - 01/2015
4	Infections 03/2024 - 01/2014
4	Infarction (Infarctions) 07/2021 - 10/2018
4	Thrombosis (Thrombus) 01/2020 - 01/2018
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2002
3	Wounds and Injuries (Trauma) 04/2024 - 01/2022
3	Colitis 12/2023 - 01/2022
3	Hemorrhage 01/2023 - 01/2019
3	Disease Progression 01/2023 - 10/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2016
3	Adenocarcinoma 01/2021 - 01/2018
3	Iron Deficiencies 03/2020 - 03/2005
3	Necrosis 01/2019 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 08/2017 - 01/2011
3	Triple Negative Breast Neoplasms 01/2017 - 02/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 04/2023 - 01/2023
2	Hyperthermia 01/2023 - 02/2015
2	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2022
2	Bites and Stings (Sting) 01/2023 - 11/2022
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 11/2022
2	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

28	Peptides (Polypeptides)IBA 10/2023 - 01/2011
22	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2012
16	IronIBA 03/2022 - 10/2006
13	VaccinesIBA 03/2024 - 09/2012
12	AntigensIBA 11/2023 - 02/2019
11	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 01/2018
10	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 11/2011
10	Cancer VaccinesIBA 11/2023 - 09/2012
9	GoldIBA 01/2023 - 04/2013
8	Small Interfering RNA (siRNA)IBA 01/2022 - 02/2015
8	Gemcitabine FDA Link 01/2022 - 04/2015
8	Ferritins (Ferritin)IBA 10/2019 - 03/2005
7	NanovaccinesIBA 03/2024 - 01/2021
7	Transferrin Receptors (Transferrin Receptor)IBA 01/2024 - 03/2005
7	Neoplasm Antigens (Tumor Antigens)IBA 10/2023 - 02/2019
7	Liposomes (Liposome)IBA 11/2021 - 02/2016
6	CytokinesIBA 02/2024 - 12/2018
6	LipidsIBA 01/2023 - 04/2015
6	RNA (Ribonucleic Acid)IBA 11/2022 - 03/2005
6	PolymersIBA 01/2022 - 10/2010
5	A-Form DNA (A-DNA)IBA 03/2024 - 01/2018
5	Messenger RNA (mRNA)IBA 07/2023 - 01/2018
5	Thromboplastin (Tissue Factor)IBA 07/2021 - 09/2015
5	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 07/2014
5	Thrombin FDA Link 01/2020 - 01/2018
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 10/2012
5	HepcidinsIBA 04/2017 - 07/2014
4	Therapeutic UsesIBA 03/2024 - 12/2015
4	pHLIP proteinIBA 10/2023 - 02/2018
4	mRNA VaccinesIBA 07/2023 - 10/2021
4	Lipid NanoparticlesIBA 07/2023 - 05/2022
4	HydrogelsIBA 03/2023 - 02/2018
4	LigandsIBA 01/2023 - 02/2014
4	Chelating AgentsIBA 03/2022 - 12/2018
4	AntioxidantsIBA 01/2022 - 01/2002
4	Angiogenesis InhibitorsIBA 01/2022 - 01/2019
4	Fibronectins (Fibronectin)IBA 01/2021 - 01/2019
4	Glutathione (Reduced Glutathione)IBA 01/2020 - 06/2018
4	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 01/2020 - 01/2017
3	SolutionsIBA 10/2023 - 04/2019
3	TicagrelorIBA 01/2023 - 01/2017
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2023 - 01/2017
3	polyethylene glycol polyethyleneimine nanogelIBA 01/2022 - 04/2013
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 06/2018
3	PlatinumIBA 01/2020 - 06/2018
3	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2018
3	FibrinIBA 01/2020 - 01/2019
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 12/2014
3	Amyloid (Amyloid Fibrils)IBA 08/2017 - 01/2011
3	Oxidopamine (6 Hydroxydopamine)IBA 09/2010 - 01/2002
2	Biocompatible Materials (Biomaterials)IBA 05/2024 - 01/2022
2	human ERBB2 proteinIBA 11/2023 - 04/2016
2	riociguatIBA 04/2023 - 01/2023
2	Prostaglandins AIBA 03/2023 - 11/2020
2	Glutamic Acid (Glutamate)FDA Link 03/2023 - 11/2019
2	ChitosanIBA 03/2023 - 01/2020
2	Estrogen ReceptorsIBA 01/2023 - 01/2019
2	Fulvestrant (Faslodex)FDA Link 01/2023 - 01/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 02/2014
2	InterferonsIBA 01/2023 - 11/2022
2	ThioredoxinsIBA 12/2022 - 02/2018

Therapy/Procedure

66	Therapeutics 03/2024 - 11/2011
24	Immunotherapy 02/2024 - 09/2012
21	Drug Therapy (Chemotherapy) 02/2024 - 10/2012
6	Lasers (Laser) 01/2023 - 11/2014
6	Photothermal Therapy 01/2022 - 11/2014
4	Precision Medicine 08/2023 - 02/2015
4	Intravenous Injections 12/2022 - 02/2018
3	Injections 01/2023 - 02/2018
3	Radiotherapy 01/2022 - 01/2018